A major neurochemical regulator of the thalamocortical network is GABA. We used J-edited MRS with compartment correction to evaluate the pharmacological effect of Dopamine agonist (DAA) therapy on thalamic GABA in patients with Parkinson’s disease (PD). Our findings suggest that DAA alters GABA release in PD patients, and that medication-induced changes may be associated to the presence of impulsive behaviors. These results provide evidence that J-edited MRS can be used to measure subcortical neurotransmitter concentration non-invasively, allowing the investigation of the pharmacological effects in GABAergic activity in humans.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords